Targeting myeloid-derived suppressor cells (MDSCs) with immune checkpoint inhibitors for treating cisplatin-resistant bladder cancer

• Y. Takeyama,
• M. Kato,
• S. Tamada,
• Y. Azuma,
• Y. Shimizu,
• T. Iguchi,
• T. Yamasaki,
• M. Gi,
• H. Wanibuchi,
• T. Nakatani

Affiliations

Y. Takeyama

M. Kato

S. Tamada

Y. Azuma

Y. Shimizu

T. Iguchi

T. Yamasaki

M. Gi

H. Wanibuchi

T. Nakatani